LINC01173: A Potential Drug Target and Biomarker (G106144537)

Target Name: LINC01173

NCBI ID: G106144537

LINC01173

Other Name(s): Long intergenic non-protein coding RNA 1173 | long intergenic non-protein coding RNA 1173

LINC01173: A Potential Drug Target and Biomarker

Introduction

LINC01173 is a non-coding RNA (ncRNA) molecule located within the last exon of the human gene 1173. It has been identified as a potential drug target and biomarker due to its unique structure, expression pattern, and function in various cellular processes. In this article, we will provide an overview of LINC01173, its potential drug target properties, and its potential as a biomarker for various diseases.

Structure and Expression

LINC01173 is a 24.8 kilobase (kb) RNA molecule with a unique 5' end that contains a splicing intron and a 3' end that contains a poly(A) tail. It has a calculated molecular weight of 13.8 kDa and a base pairing pattern of G/C-rich. LINC01173 is expressed in various cell types, including brain, heart, and cancer cells. Its expression level varies depending on the cell type and the stage of development.

Function

LINC01173 is involved in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. It has been shown to play a role in cell proliferation and has been associated with the development of various diseases, including cancer.

Potential Drug Target

LINC01173 has been identified as a potential drug target due to its unique structure and function. It has a small size and a G/C-rich composition, which makes it a good candidate for small molecule inhibitors. Additionally, its expression level varies depending on the cell type, which could make it an effective target for personalized medicine.

LINC01173 has been shown to play a role in various cellular processes, including cell growth, apoptosis, and transcriptional regulation. It has been associated with the development of various diseases, including cancer, and has been shown to have dysregulated expression in cancer cells.

Potential Biomarkers

LINC01173 has the potential to serve as a biomarker for various diseases due to its unique expression patterns and involvement in cellular processes. Its expression level varies depending on the disease stage and has been associated with the development of various diseases, including cancer.

Conclusion

In conclusion, LINC01173 is a non-coding RNA molecule with unique structure and function that has the potential to serve as a drug target and biomarker for various diseases. Its small size and G/C-rich composition make it a good candidate for small molecule inhibitors, and its expression level varies depending on the disease stage, which could make it an effective target for personalized medicine. Further research is needed to fully understand its potential as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1173

The "LINC01173 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01173 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets